UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$388M |
| 2 |
Coca-Cola
KO
|
+$291M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$263M |
| 4 |
Apple
AAPL
|
+$220M |
| 5 |
Mondelez International
MDLZ
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TAL Education Group
TAL
|
+$231M |
| 2 |
Walmart Inc
WMT
|
+$178M |
| 3 |
Yum! Brands
YUM
|
+$128M |
| 4 |
Comcast
CMCSA
|
+$122M |
| 5 |
Paycom
PAYC
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Healthcare | 14.46% |
| 3 | Consumer Discretionary | 12.94% |
| 4 | Financials | 12.31% |
| 5 | Communication Services | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
UroGen Pharma
URGN
$2.26B
| $389K | ﹤0.01% |
21,801
+5,400
| +33% | +$146K |
|
2027
Alaunos Therapeutics
TCRT
$4.84M
| $388K | ﹤0.01% |
1,056
+127
| +14% | +$65.7K |
|
2028
Wipro
WIT
$19.7B
| $388K | ﹤0.01% |
250,442
| – | – |
|
|
CPRX
2029
DELISTED
Catalyst Pharmaceutical
CPRX
| $387K | ﹤0.01% |
100,643
+6,881
| +7% | +$28.2K |
|
|
GOOD
2030
Gladstone Commercial Corp
GOOD
$618M
| $385K | ﹤0.01% |
26,833
+2,260
| +9% | +$43K |
|
|
CBPO
2031
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $385K | ﹤0.01% |
3,570
| – | – |
|
|
PFC
2032
DELISTED
Premier Financial Corp. Common Stock
PFC
| $385K | ﹤0.01% |
26,127
+17,892
| +217% | +$456K |
|
2033
Weis Markets
WMK
$1.78B
| $384K | ﹤0.01% |
9,211
-1,422
| -13% | -$54.4K |
|
|
GTS
2034
DELISTED
Triple-S Management Corporation
GTS
| $383K | ﹤0.01% |
27,195
-6,830
| -20% | -$110K |
|
2035
Customers Bancorp
CUBI
$2.78B
| $381K | ﹤0.01% |
34,819
+936
| +3% | +$18.1K |
|
2036
MarineMax
HZO
$1.15B
| $380K | ﹤0.01% |
36,437
+22,049
| +153% | +$359K |
|
2037
ArcBest
ARCB
$3.07B
| $378K | ﹤0.01% |
21,574
-8,150
| -27% | -$187K |
|
2038
Archrock
AROC
$5.81B
| $378K | ﹤0.01% |
100,477
-10,798
| -10% | -$78K |
|
|
VRS
2039
DELISTED
Verso Corporation
VRS
| $377K | ﹤0.01% |
33,410
-641
| -2% | -$9.99K |
|
|
XRN
2040
Chiron Real Estate Inc
XRN
$475M
| $377K | ﹤0.01% |
7,448
+3,288
| +79% | +$221K |
|
2041
Heritage Insurance Holdings
HRTG
$990M
| $376K | ﹤0.01% |
35,098
-3,499
| -9% | -$41.4K |
|
|
ATNX
2042
DELISTED
Athenex, Inc. Common Stock
ATNX
| $376K | ﹤0.01% |
2,426
+324
| +15% | +$81.6K |
|
|
HNGR
2043
DELISTED
Hanger Inc.
HNGR
| $375K | ﹤0.01% |
24,096
-5,624
| -19% | -$127K |
|
2044
Ethan Allen Interiors
ETD
$598M
| $373K | ﹤0.01% |
36,514
+4,915
| +16% | +$71.8K |
|
2045
Evolent Health
EVH
$444M
| $373K | ﹤0.01% |
68,632
-6,176
| -8% | -$55.2K |
|
|
THR
2046
DELISTED
Thermon Group Holdings
THR
| $371K | ﹤0.01% |
24,620
-1,779
| -7% | -$37K |
|
2047
Ingles Markets
IMKTA
$1.62B
| $370K | ﹤0.01% |
10,239
+2,000
| +24% | +$79.2K |
|
2048
The Bancorp
TBBK
$2.81B
| $367K | ﹤0.01% |
60,524
-7,815
| -11% | -$83.4K |
|
2049
Banc of California
BANC
$3B
| $366K | ﹤0.01% |
45,716
-6,515
| -12% | -$95.7K |
|
2050
Community Health Systems
CYH
$415M
| $365K | ﹤0.01% |
109,338
+31,906
| +41% | +$129K |
|
Similar funds
UBS AM's Q1 2020 Portfolio in Review
As of Q1 2020, UBS AM held 2,587 positions worth $139B, down 15% from $163B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
UBS AM deployed $7.87B of net new capital in Q1 2020, opening 62 new positions and adding to 1,446 existing holdings. Its largest new stake was Reynolds Consumer Products: 1,679,269 shares worth $49M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was TAL Education Group, an estimated $231M trimmed.
- UBS AM's largest Q1 2020 buy was Reynolds Consumer Products: 1,679,269 shares worth $49M.
- UBS AM added most to Amazon in Q1 2020, an estimated $388M increase.
- UBS AM's biggest Q1 2020 reduction was TAL Education Group, cutting an estimated $231M.
- UBS AM fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $87.1M.
- UBS AM's ten largest holdings make up 23% of its $139B portfolio in Q1 2020.
- UBS AM opened 62 new positions and closed 127 in Q1 2020.
- UBS AM's portfolio value fell 15% quarter-over-quarter to $139B.
Based on UBS AM's 13F filing for Q1 2020, filed 15 May 2020.